Search

Suda raises $5.6m for drug development

Perth-based drug company Suda has raised $5.6 million to be used for its ArTiMist malaria treatment and other development products.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
191stZipTel14%-48%
314thPainChek-2%-19%
528thBrainchip-34%26%
708thSUDA Pharmaceuticals-59%-38%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

02/08/18
$42k Sold
02/08/18
$24k Issued
02/08/18
$61k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

176th↓SUDA Pharmaceuticals$488k
178th↓JV Global$487k
179th↓Brainchip$472k
181st↓ZipTel$456k
182nd↑PainChek$434k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer